PCSK9 and familial hypercholesterolemia: Familial hypercholesterolemia is a heterogeneous disease where patients show a significant variability of phenotypes that may be explained by the polygenic nature of the disease, which has been lately enhanced by the characterization of modifier genes such as PCSK9. Typically, the severity of phenotype varies with the genotype (Sun et al., 2018).